Tag: Biosimilar
Lupin gets US-FDA nod for its Pegfilgrastim biosimilar application
The Biologics License Application (BLA) submission is supported by similarity data from analytical, pharmacokinetic, pharmacodynamic and immunogenicity studies........................
Zydus launches Ujvira, a breakthrough biosimilar for breast cancer treatment
The world’s first biosimilar Antibody Drug Conjugate of Trastuzumab Emtansine will be priced at nearly 80% less than the currently available option in the market.......................
Cadila launches Adalimumab biosimilar, Cadalimab in India
In an effort to strengthen their the biosimilar product portfolio, Cadalimab™ is the fourth biosimilar launched in the last 2 months by Cadila Pharmaceuticals..................
Cadila Pharma launches osteoporosis biosimilar in India
Ahmedabad-based Cadila Pharmaceuticals Limited launched NuPTH, an Osteoporosis biosimilar of Forteo, used for the treatment of osteoporosis and in patients with increased risk of fracture...........................
ICT-Mumbai to organize ‘Biosimilar Workshop 2020’ in February
Institute of Chemical Technology (ICT), Mumbai, is conducting the 3rd Biosimilar Workshop from February 3-8, 2020. Participants will also have the opportunity to hear from leaders of the Indian and global biopharma industry, providing a perspective on the training programs...............
Report points to bright future for biologics & biosimilars
A report on the new review released as part of the ongoing international meet on biotechnology - Global Bio India 2019, noted that the Indian pharmaceutical industry in the country was well geared to take advantage of the emerging situation.............
Alvotech & Cipla Gulf join hands to commercialize key biosimilar in...
Under the partnership, Alvotech will be responsible for development and supply of AVT02, an adalimumab biosimilar, in select emerging markets., while Cipla Gulf will be responsible for registration and commercialization....................
2019 can be a game-changer for bioscience industry?
The second last year of this decade signals towards fast nearing end of the obsolete regulations, technologies and ideas. The next decade is surely going to offer a huge leap forward to the bioscience sector in India and globally...……………..
Pharma world to discuss industry issues, showcase innovations at 70th IPC
The 70th Indian Pharmaceutical Congress will be inaugurated by Vice-President, Mr Venkaiah Naidu and will be held from December 21 to 23 at Amity University. The Industry leaders will discuss issues on APIs; generic formulations; diagnostics and medical devices..........................
Indian biosimilar market to be worth $40 billion by 2030
As per a recent paper, there is an active engagement in Indian industry with about 70 approved biosimilars yet urgent need to expand markets and de-clog RoW market access to actualize potential for global leadership...………….